Journal of Hematology & Oncology (Sep 2017)
Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
Abstract
No abstracts available.